Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
Following this news, Cardlytics stock dropped over 56% during pre-market trading on August 8, 2024.
| Ticker Symbol | Company Name | Join Deadline | Join |
|---|---|---|---|
| WOLF | Wolfspeed, Inc. | January 17, 2025 | Join |
| SUI | Sun Communities, Inc. | February 10, 2025 | Join |
| SAVA | Cassava Sciences, Inc. | February 10, 2025 | Join |
| APLT | Applied Therapeutics, Inc. | February 18, 2025 | Join |
| BIOA | BioAge Labs, Inc. | March 10, 2025 | Join |
| PCRX | Pacira BioSciences, Inc. | March 14, 2025 | Join |